These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 12759615

  • 21. Tamoxifen, screening and new oestrogen receptor modulators.
    Neven P, Vergote I.
    Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):365-80. PubMed ID: 11476559
    [Abstract] [Full Text] [Related]

  • 22. [Chemoprevention of breast cancer: a hope justified?].
    Buser K, Delaloye JF.
    Rev Med Suisse Romande; 2000 Jun; 120(6):511-3. PubMed ID: 11014095
    [Abstract] [Full Text] [Related]

  • 23. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N.
    J Natl Cancer Inst; 2005 Nov 16; 97(22):1652-62. PubMed ID: 16288118
    [Abstract] [Full Text] [Related]

  • 24. [Chemoprevention of breast cancer. Clinical trials in pharmacological prevention].
    Ricart JJ.
    Medicina (B Aires); 2004 Nov 16; 64(1):66-72. PubMed ID: 15034961
    [Abstract] [Full Text] [Related]

  • 25. The STAR (Study of Tamoxifen and Raloxifene) trial in West Virginia.
    Jubelirer SJ, Crowell EB.
    W V Med J; 2000 Nov 16; 96(6):602-4. PubMed ID: 11194089
    [Abstract] [Full Text] [Related]

  • 26. Chemoprevention of breast cancer: recommendations and rationale.
    U.S. Preventive Services Task Force.
    Ann Intern Med; 2002 Jul 02; 137(1):56-8. PubMed ID: 12093249
    [No Abstract] [Full Text] [Related]

  • 27. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ, Jones ME, British Tamoxifen Second Cancer Study Group.
    J Natl Cancer Inst; 2005 Mar 02; 97(5):375-84. PubMed ID: 15741574
    [Abstract] [Full Text] [Related]

  • 28. Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint.
    Fabian C.
    Cancer Epidemiol Biomarkers Prev; 2007 Nov 02; 16(11):2210-2. PubMed ID: 18006909
    [No Abstract] [Full Text] [Related]

  • 29. Summaries for patients. Using medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force.
    Ann Intern Med; 2013 Nov 19; 159(10):I-28. PubMed ID: 24400336
    [No Abstract] [Full Text] [Related]

  • 30. Hormonal interventions to prevent hormonal cancers: breast and prostate cancers.
    Dunn BK, Ford LG.
    Eur J Cancer Prev; 2007 Jun 19; 16(3):232-42. PubMed ID: 17415094
    [Abstract] [Full Text] [Related]

  • 31. NICE recommends preventive drugs for breast cancer.
    Wise J.
    BMJ; 2013 Jun 25; 346():f4116. PubMed ID: 23801701
    [No Abstract] [Full Text] [Related]

  • 32. Tamoxifen and raloxifene may benefit women at high risk for breast cancer.
    Rollins G.
    Rep Med Guidel Outcomes Res; 2002 Jul 26; 13(14):1-2, 5. PubMed ID: 12518771
    [No Abstract] [Full Text] [Related]

  • 33. SERMs: meeting the promise of multifunctional medicines.
    Jordan VC.
    J Natl Cancer Inst; 2007 Mar 07; 99(5):350-6. PubMed ID: 17341726
    [Abstract] [Full Text] [Related]

  • 34. The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women.
    Bevers TB.
    J Natl Compr Canc Netw; 2007 Sep 07; 5(8):719-24. PubMed ID: 17927929
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The rise of raloxifene and the fall of invasive breast cancer.
    Jordan VC.
    J Natl Cancer Inst; 2008 Jun 18; 100(12):831-3. PubMed ID: 18544739
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Breast cancer chemoprevention (tamoxifen, raloxifene, and others)].
    Funahashi H.
    Nihon Rinsho; 2000 Apr 18; 58 Suppl():587-91. PubMed ID: 11026055
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.